Finally, we show that the correction of the defect with TNFR2 agonism has functional consequences in vitro: it suppresses autologous CD8 T-cell proliferation, which is highly desirable in thwarting autoimmunity. The gene discussed is TNFRSF1B; the disease is Autoimmunity.